Company Presentation: NuvOx
NuvOx Pharma is a biotechnology company based in Tucson, Arizona with a novel patent portfolio allowing it to develop an innovative platform of dodecafluoropentane (DDFP)-based oxygen therapeutics to treat a host of human conditions. Founded in 2008, NuvOx Pharma has demonstrated therapeutic feasibility in radiation-resistant cancer, hemorrhagic shock, traumatic brain injury, myocardial infarction, retinopathy and stroke. Due to inherent structure of DDFP, a very stable and relative lack of inter-molecular attractive forces, this perfluorocarbon is known to carry large payloads of oxygen in the bloodstream. The main advantage to using DDFP is that it is a liquid at room temperature, but expands to the gas state in the body. Therefore, upon intravenous injection the transition of DDFP from a liquid to a gas in the bloodstream allows for ~600 times increased oxygen transport compared to Hemoglobin.
2012 Bioscience Company of the Year - Cord Blood Registry
The first cord blood sample ever saved by a family belonged to the son of CBR's Scientific Director. Two decades later, CBR (Cord Blood Registry) is the largest, most experienced stem cell bank, entrusted by families worldwide. Thanks to expecting families like yours, more than 400,000 children have newborn stem cells saved with CBR. As you decide what's best for your family, it's important to understand the CBR difference in quality and experience. CBR has banked more stem cells than any other family bank and has the most experience helping families use their cord blood for medical treatments. In October 2012, CBR was named the Arizona Bioscience Company of the Year.
STEM: Nadja Anderson Interview Part 2
2011 Bioscience Educator of the Year, Dr. Nadja Anderson, director of the BIOTECH Project for University of Arizona’s BIO5 Institute, shows some the materials used to demonstrate DNA extraction at science festivals and during classroom visits. Read the article Biosciences Education >>
Championing Patient Safety: Ventana
Anatomic pathology labs today face critical shortages in technicians, along with increasing demands to produce better quality results, faster.While the average pathology lab maintains a 99% quality rate, that leaves a 1% margin for error that could mean as many as 6 misidentified samples every single week for an average size lab*. When real patient results are at risk, even a small margin of error is unacceptable. Now, more than ever, we must safeguard every patient...every step of the way.Here, you will learn about pathology lab process errors that compromise the integrity of patient results, and the solutions that can put your lab on a SaferPath.
Ventana Medical Systems, Inc.08/15/2013
Ventana Case Study: Yuma Regional Medical Center and digital pathology
At Yuma Regional Medical Center in Yuma, Arizona, the anatomical pathology lab has adopted cutting edge digital pathology solutions from Ventana Medical Systems, Inc. to increase their efficiencies and to assist in better patient care.
Leslie Boyer, MD 2013 Arizona Bioscience Researcher of the Year
In 2013, Dr. Leslie Boyer was been named one of 30 heroes of rare diseases by the Food and Drug Administration’s Office of Orphan Products Development. Her work includes a clinical studies program conducted throughout Arizona with protocols for placebo-controlled, double-blind trials, open-label studies, historical control studies, and the statewide STING project. She has coordinated phase 2 and phase 3 multicenter clinical trials of pit viper antivenom, developed the Antivenom Index, and participated in the establishment of the Pan-American Lymphotoxinology Taskforce. Boyer, who is a member of the UA’s BIO5 Institute, has focused her scientific career on venomous bites and stings, which are often unrecognized public health issues. She began by developing public education programs that offer poison and toxin emergency treatment advice. In 2004 and 2005, with an FDA Orphan Product grant, she led a team that conducted clinical studies leading to the marketing approval of the first scorpion antivenom – representing one of more than 40 products developed through orphan grant-sponsored research.
CBR - 20 Years of Cord Blood Research
Cord blood stem cells have been used to treat more than 80 diseases, from leukemias and anemias to immune and metabolic disorders. Today, even more treatment options are being evaluated in cutting-edge, FDA-regulated clinical trials. This growing number of potential uses means more medical options for your family later.
Bio Ag: Foresight and Integrating Vision Systems
The University of Arizona Controlled Environment Agriculture Center Controlled Environment Agriculture (CEA) is the production of plants and their products, such as vegetables and flowers, inside structures such as greenhouses. By using CEA, we can produce high value crops at maximum productivity in an efficient and environmentally friendly way. The University of Arizona's Controlled Environment Agriculture Center (CEAC) supports education, research and outreach as part of the Department of Agricultural & Biosystems Engineering and the School of Plant Sciences - both programs of the College of Agriculture and Life Sciences. CEAC also offers an innovation platform for plant physiology, sensor technology and applied computer technology.